[go: up one dir, main page]

HUP9800688A3 - Complex of gamma-cyclodextrin and retinol or retinol derivatives, process for their production and cosmetic an pharmaceutical compositions containing them - Google Patents

Complex of gamma-cyclodextrin and retinol or retinol derivatives, process for their production and cosmetic an pharmaceutical compositions containing them

Info

Publication number
HUP9800688A3
HUP9800688A3 HU9800688A HUP9800688A HUP9800688A3 HU P9800688 A3 HUP9800688 A3 HU P9800688A3 HU 9800688 A HU9800688 A HU 9800688A HU P9800688 A HUP9800688 A HU P9800688A HU P9800688 A3 HUP9800688 A3 HU P9800688A3
Authority
HU
Hungary
Prior art keywords
retinol
cyclodextrin
cosmetic
gamma
complex
Prior art date
Application number
HU9800688A
Other languages
English (en)
Original Assignee
Wacker Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wacker Chemie Ag filed Critical Wacker Chemie Ag
Publication of HUP9800688A2 publication Critical patent/HUP9800688A2/hu
Publication of HUP9800688A3 publication Critical patent/HUP9800688A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/738Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/004Aftersun preparations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12Face or body powders for grooming, adorning or absorbing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9800688A 1997-03-27 1998-03-27 Complex of gamma-cyclodextrin and retinol or retinol derivatives, process for their production and cosmetic an pharmaceutical compositions containing them HUP9800688A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19713092A DE19713092A1 (de) 1997-03-27 1997-03-27 Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (2)

Publication Number Publication Date
HUP9800688A2 HUP9800688A2 (hu) 1999-02-01
HUP9800688A3 true HUP9800688A3 (en) 1999-04-28

Family

ID=7824924

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800688A HUP9800688A3 (en) 1997-03-27 1998-03-27 Complex of gamma-cyclodextrin and retinol or retinol derivatives, process for their production and cosmetic an pharmaceutical compositions containing them

Country Status (7)

Country Link
US (1) US5985296A (hu)
EP (1) EP0867175B1 (hu)
JP (1) JP3010435B2 (hu)
KR (1) KR100304382B1 (hu)
CA (1) CA2233108C (hu)
DE (2) DE19713092A1 (hu)
HU (1) HUP9800688A3 (hu)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1134249C (zh) * 1997-11-27 2004-01-14 株式会社资生堂 面膜化妆品
DE19847633C1 (de) * 1998-10-15 2000-03-02 Wacker Chemie Gmbh Verfahren zur Komplexierung von Retinol mit gamma-Cyclodextrin
DE19943678A1 (de) * 1999-09-13 2001-03-15 Beiersdorf Ag Wirkstoffkombinationen aus oberflächenaktiven Citronensäureestern und Einschlußverbindungen von Cyclodextrinen und Retinoiden sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
JP2004504276A (ja) * 2000-06-26 2004-02-12 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン ヒトの皮膚の光老化を防止するためのegf−rタンパク質チロシンキナーゼ抑制剤の使用
KR100402576B1 (ko) * 2000-07-05 2003-10-22 동아제약 주식회사 레티놀을 다중 안정화시켜 함유하는 화장료
IT1317911B1 (it) * 2000-09-28 2003-07-15 Idi Irccs Formulazione cosmetica.
KR100437102B1 (ko) * 2001-01-11 2004-06-23 (주)케비젠 신규한 레티놀 유도체, 그 제조방법 및 그 용도
EP1370294A2 (en) * 2001-02-27 2003-12-17 The Regents Of The University Of Michigan Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor
DE10141682A1 (de) * 2001-08-25 2003-03-06 Beiersdorf Ag Verwendung von Cyclodextrinen zur Herstellung kosmetischer und dermatologischer Zubereitungen mit verbesserter Verteilbarkeit von Füllstoffen auf der Haut sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an Cyclodextrinen und Füllstoffen
DE10151245A1 (de) * 2001-10-17 2003-05-15 Beiersdorf Ag Kosmetische und/oder dermatologische Wirkstoffkombination
EP1304161B1 (en) * 2001-10-19 2007-02-28 Pacific Corporation Thermotropic liquid crystal polymer microcapsules, a method for preparing the same, and cosmetic compositions containing the same
JP4528903B2 (ja) * 2002-03-11 2010-08-25 石川県 植物含有有効成分のサイクロデキストリン包接物の製造方法
DE10224298A1 (de) * 2002-05-31 2003-12-18 Beiersdorf Ag Kosmetische Stoffkombinationen
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
FI20030426L (fi) * 2003-03-24 2004-09-25 Tomi Jaervinen Syklodekstriinikompleksit
US20060177405A1 (en) * 2005-02-04 2006-08-10 Morrissey Maureen S Moisturizing compositions
CA2610471A1 (en) * 2005-06-13 2006-12-28 Cargill, Incorporated Cyclodextrin inclusion complexes and methods of preparing same
BRPI0611925A2 (pt) * 2005-06-13 2010-10-13 Cargill Inc complexos de inclusão de ciclodextrina e métodos de preparação dos mesmos
KR101397976B1 (ko) * 2006-05-02 2014-05-27 가부시키가이샤 도요학코 세포 부활용 피부외용제 조성물 및 그 제조방법
MX2008016022A (es) * 2006-06-13 2009-01-15 Cargill Inc Complejos de inclusion de ciclodextrina de particula grande y metodos para prepar los mismos.
EP2065433B1 (en) * 2006-09-22 2011-12-21 Kurabe Industrial Co., Ltd Ptfe porous body, ptfe mixture, method for producing ptfe porous body, and electric wire/cable using ptfe porous body
EP2049083A2 (en) * 2006-12-27 2009-04-22 Cargill, Incorporated Stabilisation by preparing cyclodextrin inclusion complexes
US20080283693A1 (en) * 2007-05-15 2008-11-20 Evans Michael J F Propulsion apparatus and system
DE102007051614A1 (de) * 2007-10-24 2009-04-30 Coty Prestige Lancaster Group Gmbh Retinolhaltiges Kosmetikprodukt
DE102008022041A1 (de) * 2008-04-29 2009-11-05 Coty Prestige Lancaster Group Gmbh Kosmetisches Erzeugnis mit verzögerter Retinolfreisetzung
US8410079B2 (en) 2010-08-06 2013-04-02 Island Kinetics Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion
BR112014023379A8 (pt) * 2012-03-22 2017-07-25 Prec Dermatology Inc Microemulsões com base em ciclodextrina e usos dermatológicos das mesmas
DK2903588T3 (da) * 2012-10-02 2020-05-11 Allergan Inc Dermale fyldstofhydrogeler med vitamin a-/cyclodextrininklusionskomplekser
CA3289338A1 (en) 2013-03-12 2025-11-29 Primal Therapies, Inc. Dental composition comprising chelator and base
KR101503301B1 (ko) * 2013-07-22 2015-03-17 주식회사 웰코스 레티닐팔미테이트 안정화 조성물
EP3290026A1 (en) 2016-09-06 2018-03-07 Athenion AG Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
EP3421096A1 (en) 2017-06-30 2019-01-02 Athenion AG Method for solubilizing poorly water-soluble cosmetic agents
EP3746127A1 (en) * 2018-01-30 2020-12-09 Olusola Clement Idowu Mangiferin as a protective agent against mitochondrial dna damage and skin-care compositions comprising same
CN112294693B (zh) * 2019-07-26 2021-07-20 珀莱雅化妆品股份有限公司 一种视黄醇及其衍生物的超分子制剂及其制备方法
CN110623859A (zh) * 2019-10-25 2019-12-31 广州市博之越精细化工有限公司 一种羟丙基环糊精包合视黄醇的制备方法
KR102297632B1 (ko) * 2021-04-19 2021-09-06 주식회사 라파스 레티놀 안정화를 위한 사이클로덱스트린을 포함하는 마이크로니들 제조용 조성물 및 이러한 조성물로 제조된 마이크로니들
CN113181078A (zh) * 2021-05-21 2021-07-30 何平蓉 一种滋润收敛型深层清洁面膜粉
CN113244157A (zh) * 2021-06-04 2021-08-13 何平蓉 一种防暗沉持妆粉饼及其制备方法
CN113318027A (zh) * 2021-06-15 2021-08-31 何平蓉 一种温和型控油祛痘洁面组合物及其制备方法
CN114869797B (zh) * 2022-03-22 2023-07-21 深圳市美莲达生物科技有限公司 含有视黄醇和黄精多糖的精华液及其应用
CN114652659B (zh) * 2022-05-10 2023-07-14 广州兰蝶生物科技有限公司 一种含芦荟和玫瑰纯露的保湿凝胶
CN115381732B (zh) * 2022-08-01 2023-05-12 广州市博之越精细化工有限公司 一种羟丙基环糊精包合视黄醇的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
EP0335545B2 (en) * 1988-03-29 1998-09-23 University Of Florida Pharmaceutical formulations for parenteral use
JP2779424B2 (ja) * 1988-10-19 1998-07-23 日清製粉株式会社 α−トコフエロールビタミンA酸エステル−シクロデキストリン複合体
FR2647015B1 (fr) * 1989-05-17 1994-05-06 Cird Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique
DE69006259T2 (de) * 1989-05-24 1994-06-09 Innovet Inc Hypoallergene anästhesierende/hypnotische steroide Arzneizubereitung.
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
CA2013485C (en) * 1990-03-06 1997-04-22 John Michael Gardlik Solid consumer product compositions containing small particle cyclodextrin complexes
ATE365530T1 (de) * 1992-07-13 2007-07-15 Shiseido Co Ltd Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
SE9300971D0 (sv) * 1993-03-24 1993-03-24 Jan Wadstein Hudvaardskomposition
ATE196427T1 (de) * 1993-12-06 2000-10-15 Takeda Chemical Industries Ltd Zusammensetzung mit verbesserter wasserlöslichkeit, enthaltend eine wasserunlösliche oder an wasser schwerunlösliche verbindung

Also Published As

Publication number Publication date
EP0867175B1 (de) 2000-08-09
KR100304382B1 (ko) 2002-04-24
DE59800221D1 (de) 2000-09-14
DE19713092A1 (de) 1998-10-01
KR19980080135A (ko) 1998-11-25
CA2233108A1 (en) 1998-09-27
JP3010435B2 (ja) 2000-02-21
US5985296A (en) 1999-11-16
EP0867175A1 (de) 1998-09-30
CA2233108C (en) 2005-07-26
JPH10279504A (ja) 1998-10-20
HUP9800688A2 (hu) 1999-02-01

Similar Documents

Publication Publication Date Title
HUP9800688A3 (en) Complex of gamma-cyclodextrin and retinol or retinol derivatives, process for their production and cosmetic an pharmaceutical compositions containing them
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9602511A2 (en) Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
HUP9802422A3 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
AU4821096A (en) Benzazepine-, benzoxazepine- and benzothiazepine-N-acetic derivatives, process for their preparation and pharmaceutical compositions containing them
HU9602489D0 (en) New piperazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9802694A3 (en) Benzamide derivatives, process for producing them and pharmaceutical compositions containing them
HUP0001802A3 (en) Pyrazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9900120A3 (en) Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9802323A3 (en) Pyrimidine derivatives , process for producing them and pharmaceutical compositions containing them
HUP9600071A3 (en) Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9602681A1 (en) Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9603023A3 (en) Substituted (sulfonimidamido)benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9802653A3 (en) Substituted imidazolidine derivatives, process for producing them, and pharmaceutical compositions containing them
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9901153A3 (en) Azetidinone derivatives for the treatment of atherosclerosis, their production and pharmaceutical compositions containing them
HU9800781D0 (en) Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use
HUP0002300A3 (en) Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use
GB9617893D0 (en) New pharmaceutical derivatives, process for obtaining them and pharmaceutical compositions containing them
HUP9801423A3 (en) Chromene derivatives, process for producing them and pharmaceutical compositions containing them
HUP9901190A3 (en) Sulfonamide derivatives of imidazole, process for producing them and pharmaceutical compositions containing them
IL141954A0 (en) Benzothiazolone derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: WACKER CHEMIE AG, DE

Free format text: FORMER OWNER(S): WACKER-CHEMIE GMBH., DE

FD9A Lapse of provisional protection due to non-payment of fees